S. 2979: Preventing Opioid and Drug Impairment in Transportation Act

Before you vote › Federal bills

S. 2979: Preventing Opioid and Drug Impairment in Transportation Act

116th Congress · introduced 2019-12-04 · Transportation and Public Works · Latest: Placed on Senate Legislative Calendar under General Orders. Calendar No. 634.

federal

Save to my notebook What does this mean? Print

Official title

Preventing Opioid and Drug Impairment in Transportation Act

Plain summary

Preventing Opioid and Drug Impairment in Transportation Act This bill addresses drug and alcohol testing for transportation-related activities. Specifically, the bill requires the National Railroad Passenger Corporation (Amtrak) to report on methods it uses to ensure supervisors of employees in safety-sensitive positions receive the required training on how to detect drug and alcohol use and training on the rights and responsibilities of employees throughout the drug and alcohol testing process; the Department of Transportation (DOT) to determine whether to mandate that Amtrak locomotive engineers and conductors report arrests due to drug or alcohol offenses; DOT to report on the ability of pipeline companies that operate from Canada or Mexico into the United States to conduct the same drug and alcohol tests of safety-sensitive personnel that are required in the United States; DOT to amend its auditing program to improve the efficiency of certain drug and alcohol regulations related to testing contractors working in multiple states; the National Highway Traffic Safety Administration to study the ways it can reduce and better detect impaired driving, including marijuana- and opioid-impaired driving; DOT to conduct a study on the accuracy of on-site oral fluid screening for tetrahydrocannabinol and opiate presence in order to reduce the potential impact on traffic safety due to drug and polysubstance-impaired drivers; the Government Accountability Office to review DOT's process for setting guidelines and drug testing requirements for transportation employees; reports on whether to add fentanyl to the drug testing panel and the status of the guidelines for hair testing of transportation employees; DOT to report on the current status and operational potential of the Driver Alcohol Detection System for Safety Program's alcohol detection technology; and DOT to identify the barriers states face in submitting toxicology results of fatally injured drivers, provide recommendations to address such barriers, and establish minimum guidelines for toxicological investigations.

Congressional Research Service summary (Reported to Senate), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Sen. Wicker, Roger F. [R-MS] · 0 cosponsors

Cost estimate: CBO cost estimate: S. 2979, Preventing Opioid and Drug Impairment in Transportation Act (2020-02-14)

Sponsor's campaign money: Sen. Wicker, Roger F. [R-MS] reported raising $306,823 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

• Congressional Research Service summary (Reported to Senate)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-116s2979.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s>

Record fed-us-cong116-s2979 · catalog fed-us-congress-bills-cong116 · updated 2026-11-15 by psicol fed-bills-cong116